J Korean Med Sci.  2006 Dec;21(6):1028-1032. 10.3346/jkms.2006.21.6.1028.

The Prevalence and Evolution of Anemia Associated with Tuberculosis

• Lee SW
• Kang YA
• Yoon YS
• Um SW
• Lee SM
• Yoo CG
• Kim YW
• Han SK
• Shim YS
• Yim JJ

• KMID: 1713113
• DOI: http://doi.org/10.3346/jkms.2006.21.6.1028

Abstract

Tuberculosis (TB) may produce abnormalities in the peripheral blood, including anemia. However, the evolution of TB-associated anemia with short-term combination anti-TB chemotherapy has not been well elucidated. The aim of this study was to characterize TB-associated anemia by clarifying its prevalence, characteristics, and evolution, through involving large numbers of patients with TB. The medical records of adult patients with TB diagnosed between June 2000 and May 2001 were reviewed. Among 880 patients with TB, 281 (31.9%) had anemia on diagnosis of TB, however, the hemoglobin concentration was less than 10 g/dL in only 45 patients (5.0%). Anemia was more frequently associated with the female and old age. Good treatment response, young age (< or =65 yr-old) and initial high hemoglobin were the predictive factor for resolution of anemia. In 202 patients with anemia (71.9%), anemia was normocytic and normochromic. During or after anti-TB treatment, anemia was resolved in 175 (64.6%) out of 271 patients without iron intake. The mean duration of resolution from the initiation of anti-TB treatment was 118.8+/-113.2 days. In conclusion, anemia is a common hematological abnormality in patients with TB and close observation is sufficient for patients with TB-associated anemia, because TBassociated anemia is usually mild and resolves with anti-TB treatment.

Keyword

Tuberculosis; Anemia; Treatment; Treatment Outcome

MeSH Terms

Tuberculosis/*epidemiology
Sex Distribution
Risk Factors
Risk Assessment/*methods
Prevalence
Middle Aged
Male
Korea/epidemiology
Humans
Female
Comorbidity
Causality
Anemia/*epidemiology
Aged, 80 and over
Aged
Age Distribution
Adult

Figure

• 

  Fig. 1 Prevalence and evolution of anemia in 892 patients with TB. *hemoglobin.

Reference

1. Corbett EL, Watt CJ, Walker N, Maher D, Williams BG, Raviglione MC, Dye C. The growing burden of tuberculosis: global trends and interactions with the HIV epidemic. Arch Intern Med. 2003. 163:1009–1021.

2. Baynes RD, Flax H, Bothwell TH, Bezwoda WR, Atkinson P, Mendelow B. Red blood cell distribution width in the anemia secondary to tuberculosis. Am J Clin Pathol. 1986. 85:226–229.

3. Baynes RD, Flax H, Bothwell TH, Bezwoda WR, MacPhail AP, Atkinson P, Lewis D. Haematological and iron-related measurements in active pulmonary tuberculosis. Scand J Haematol. 1986. 36:280–287.

4. Aziz R, Khan AR, Qayum I, ul Mannan M, Khan MT, Khan N. Presentation of pulmonary tuberculosis at Ayub Teaching Hospital Abbottabad. J Ayub Med Coll Abbottabad. 2002. 14:6–9.

5. Morris CD, Bird AR, Nell H. The haematological and biochemical changes in severe pulmonary tuberculosis. Q J Med. 1989. 73:1151–1159.

6. Olaniyi JA, Aken'Ova YA. Haematological profile of patients with pulmonary tuberculosis in Ibadan, Nigeria. Afr J Med Med Sci. 2003. 32:239–242.

7. Ali-Gombe A, Onadeko BO. Serum calcium levels in patients with active pulmonary tuberculosis. Afr J Med Med Sci. 1997. 26:67–68.

8. Cameron SJ, Horne NW. The effect of tuberculosis and its treatment on erythropoiesis and folate activity. Tubercle. 1971. 52:37–48.

9. Corr WP Jr, Kyle RA, Bowie EJ. Hematologic changes in tuberculosis. Am J Med Sci. 1964. 248:709–714.

10. Klipstein FA, Berlinger FC, Reed LJ. Folate deficiency associated with drug therapy for tuberculosis. Blood. 1967. 29:697–712.

11. Roberts PD, Hoffbrand AV, Mollin DL. Iron and folate metabolism in tuberculosis. Br Med J. 1966. 5507:198–202.

12. DeMaeyer E, Adiels-Tegman M. The prevalence of anaemia in the world. World Health Stat Q. 1985. 38:302–316.

13. Weiss G. Pathogenesis and treatment of anaemia of chronic disease. Blood Rev. 2002. 16:87–96.

14. Means RT Jr. Recent developments in the anemia of chronic disease. Curr Hematol Rep. 2003. 2:116–121.

15. Weiss G, Goodnough LT. Anemia of chronic disease. N Engl J Med. 2005. 352:1011–1023.

16. Schwenk A, Macallan DC. Tuberculosis, malnutrition and wasting. Curr Opin Clin Nutr Metab Care. 2000. 3:285–291.

17. Ramadan IT, Abdul-Ghaffar NU. Malabsorption syndrome complicating tuberculous peritonitis. Int J Tuberc Lung Dis. 1997. 1:85–86.

18. Choi CW, Lee J, Park KH, Yoon SY, Choi IK, Oh SC, Seo JH, Kim BS, Shin SW, Kim YH, Kim JS. Prevalence and characteristics of anemia in the elderly: cross-sectional study of three urban Korean population samples. Am J Hematol. 2004. 77:26–30.

19. Ania BJ, Suman VJ, Fairbanks VF, Melton LJ 3rd. Prevalence of anemia in medical practice: community versus referral patients. Mayo Clin Proc. 1994. 69:730–735.

20. Ania BJ, Suman VJ, Fairbanks VF, Rademacher DM, Melton LJ 3rd. Incidence of anemia in older people: an epidemiologic study in a well defined population. J Am Geriatr Soc. 1997. 45:825–831.

21. Balducci L. Epidemiology of anemia in the elderly: information on diagnostic evaluation. J Am Geriatr Soc. 2003. 51:S2–S9.

22. Smith DL. Anemia in the elderly. Am Fam Physician. 2000. 62:1565–1572.

23. Ricci C, Cova M, Kang YS, Yang A, Rahmouni A, Scott WW Jr, Zerhouni EA. Normal age-related patterns of cellular and fatty bone marrow distribution in the axial skeleton: MR imaging study. Radiology. 1990. 177:83–88.

24. Henderson JG, Strachan RW, Beck JS, Dawson AA, Daniel M. The antigastric-antibody test as a screening procedure for vitamin-B12 deficiency in psychiatric practice. Lancet. 1966. 2:809–813.

25. Ludwiczek S, Aigner E, Theurl I, Weiss G. Cytokine-mediated regulation of iron transport in human monocytic cells. Blood. 2003. 101:4148–4154.

26. Tilg H, Ulmer H, Kaser A, Weiss G. Role of IL-10 for induction of anemia during inflammation. J Immunol. 2002. 169:2204–2209.

27. Cronje L, Bornman L. Iron overload and tuberculosis: a case for iron chelation therapy. Int J Tuberc Lung Dis. 2005. 9:2–9.

28. Hallberg L, Hulthen L, Bengtsson C, Lapidus L, Lindstedt G. Iron balance in menstruating women. Eur J Clin Nutr. 1995. 49:200–207.

29. Jelkmann W. Proinflammatory cytokines lowering erythropoietin production. J Interferon Cytokine Res. 1998. 18:555–559.

30. Bozoky G, Ruby E, Goher I, Toth J, Mohos A. Hematologic abnormalities in pulmonary tuberculosiss. Orv Hetil. 1997. 138:1053–1056.